ライフサイエンスコーパス: cognitive deterioration

1 y any statistically significant predictor of cognitive deterioration.

2 ncreases amyloid burden, although preventing cognitive deterioration.

3 urosurgery carries the risk of postoperative cognitive deterioration.

4 t epilepsy, and progressive neurological and cognitive deterioration.

5 er TAVI, despite the high intrinsic risk for cognitive deterioration.

6 oligomeric peptides, known to be involved in cognitive deterioration.

7 uvignon modulates AD-type neuropathology and cognitive deterioration.

8 mild cognitive impairment and aging-related cognitive deterioration.

9 Only a small percentage of patients had cognitive deterioration after radiotherapy.

10 esults confirm that some patients experience cognitive deterioration after TAVI.

11 cantly slower rate of functional, motor, and cognitive deterioration (all p < 0.001), independent of

12 genetic effects on the processes leading to cognitive deterioration and Alzheimer's disease.

13 richment may reduce the risk of experiencing cognitive deterioration and dementia in later-life.

14 nt was associated with an increased risk for cognitive deterioration and dementia.

15 al stage of Alzheimer's disease and predicts cognitive deterioration and disease-associated changes i

16 score can be used to increase vigilance for cognitive deterioration and for selection of high-risk p

17 disorder characterized by motor impairment, cognitive deterioration and psychiatric disturbances fol

18 al-AZ (MN), significantly attenuated AD-type cognitive deterioration and reduced cerebral amyloid dep

19 clinical stage of AD and is associated with cognitive deterioration and structural brain changes ove

20 The disease results in blindness, motor and cognitive deterioration, and seizures.

21 human loci that protect against age-related cognitive deterioration arising from neurodegenerative d

22 There was less cognitive deterioration at 3 months after SRS alone (40/

23 ith SRS combined with WBRT, resulted in less cognitive deterioration at 3 months.

24 [HR] 0.47 [95% CI 0.35-0.63]; p<0.0001), and cognitive deterioration at 6 months was less frequent in

25 gelastic seizures are often associated with cognitive deterioration, behavioral problems, and poor r

26 copolamine revealed that ovariectomy-induced cognitive deterioration coincided with a compromised cho

27 preparation significantly attenuates AD-type cognitive deterioration coincidentally with reduced HMW

28 ssion who experienced clinically significant cognitive deterioration compared with baseline was stabl

29 The primary end point was cognitive deterioration (decline >1 SD from baseline on

30 attenuated the development of Abeta-mediated cognitive deterioration, even when delivered at a dose a

31 The co-primary endpoints were cognitive-deterioration-free survival and overall surviv

32 Cognitive-deterioration-free survival was longer in pati

33 nce and Kruskal-Wallis analysis; the odds of cognitive deterioration (> or =3-point decline on the mo

34 ify risk factors associated with significant cognitive deterioration (>10% decline).

35 brocortical regions to the earliest signs of cognitive deterioration in AD.

36 ) visible on MRI are associated with SVD and cognitive deterioration in older individuals is unknown.

37 tigated functional hub load and postsurgical cognitive deterioration in patients undergoing lesion re

38 We confirmed the presence of a widespread cognitive deterioration in PP-MS patients, with main inv

39 nce activity rhythms will reduce the risk of cognitive deterioration in the elderly.

40 e, whether their presence is associated with cognitive deterioration in the general population remain

41 incorrect assumptions that neurotoxicity or cognitive deterioration may be avoided.

42 Furthermore, the behavioral and cognitive deterioration observed in late life did not co

43 Cognitive deterioration occurred in 1 patient and electr

44 der from the psychosis and severe social and cognitive deterioration of chronic schizophrenia.

45 Cognitive deterioration or improvement was defined as ch

46 No significant cognitive deterioration or loss of language occurred, an

47 Whereas some contribute to progressive cognitive deterioration, others lower the level of cogni

48 roportion of high-grade glioma patients with cognitive deterioration over time is stable, most consis

49 In view of the minimal cognitive deterioration overall in this group, this sugg

50 ment (MCI), an early stage of age-associated cognitive deterioration, underwent cognitive testing, in

51 Odds ratios for cognitive deterioration using 0 to 2 symptoms as the ref

52 Cognitive deterioration was found in 29 patients (12.7%)

53 For long-term survivors, the incidence of cognitive deterioration was less after SRS alone at 3 mo

54 asingly recognized as a general mechanism of cognitive deterioration with aging.